These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 10394964
1. An effective and more convenient drug regimen for prophylaxis against paclitaxel-associated hypersensitivity reactions. Markman M, Kennedy A, Webster K, Peterson G, Kulp B, Belinson J. J Cancer Res Clin Oncol; 1999 Jul; 125(7):427-9. PubMed ID: 10394964 [Abstract] [Full Text] [Related]
2. A comparison of two prophylactic regimens for hypersensitivity reactions to paclitaxel. Kwon JS, Elit L, Finn M, Hirte H, Mazurka J, Moens F, Trim K. Gynecol Oncol; 2002 Mar; 84(3):420-5. PubMed ID: 11855881 [Abstract] [Full Text] [Related]
3. Premedication strategy for weekly paclitaxel. Quock J, Dea G, Tanaka M, Gandara D, Lara P, Lau D. Cancer Invest; 2002 Mar; 20(5-6):666-72. PubMed ID: 12197222 [Abstract] [Full Text] [Related]
5. [Paclitaxel hypersensitivity reactions in patients with advanced ovarian carcinoma]. Kobierski J, Majdak E, Mielcarek P, Emerich J. Ginekol Pol; 2002 Nov; 73(11):1015-20. PubMed ID: 12722392 [Abstract] [Full Text] [Related]
6. Preliminary experience with a modified premedication protocol that included intravenous diphenhydramine and calcium bromide for the prophylaxis of paclitaxel-related hypersensitivity reactions. Sasada S, Hirashima T, Nakamura Y, Takimoto T, Furukawa M, Kobayashi M, Nitta T, Matsui K, Kawase I. Int J Clin Oncol; 2007 Aug; 12(4):274-8. PubMed ID: 17701006 [Abstract] [Full Text] [Related]
7. Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center. Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J. J Clin Oncol; 2000 Jan; 18(1):102-5. PubMed ID: 10623699 [Abstract] [Full Text] [Related]
8. Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens. Kloover JS, den Bakker MA, Gelderblom H, van Meerbeeck JP. Br J Cancer; 2004 Jan 26; 90(2):304-5. PubMed ID: 14974481 [Abstract] [Full Text] [Related]